St. Jude Scientists Discover Midkine Protein’s Protective Role Against Alzheimer’s

In a significant breakthrough for Alzheimer’s research, scientists at St. Jude Children’s Research Hospital have demonstrated for the first time that the protein midkine plays a preventative role against the disease. The study, led by Dr. Junmin Peng and published in Nature Structural & Molecular Biology, reveals a direct connection between midkine and amyloid beta, the protein notorious for forming the toxic plaques that are a hallmark of Alzheimer’s.

Unveiling Midkine’s Mechanism

While midkine has long been known to accumulate in the brains of Alzheimer’s patients, its specific function was a mystery. Dr. Peng’s team, using a combination of advanced techniques including fluorescence assays and nuclear magnetic resonance, found that midkine directly inhibits the formation and growth of amyloid beta assemblies. This protective action works on two specific phases: elongation and secondary nucleation, effectively halting the process by which amyloid beta aggregates into harmful plaques.

The researchers confirmed this protective role in animal models. By studying Alzheimer’s disease mouse models that have increased amyloid beta, they demonstrated that the absence of the midkine gene led to even higher levels of amyloid beta accumulation. This finding provides compelling evidence that the protein actively works to combat the disease’s progression.

A New Avenue for Drug Discovery

This discovery is a critical step forward, as it provides a promising new target for therapeutic development. Previous Alzheimer’s research has primarily focused on clearing existing amyloid beta plaques, with limited success. This new understanding of midkine’s preventive mechanism offers a novel strategy: designing drugs that mimic or enhance midkine’s ability to inhibit amyloid beta assembly from the start.

“We want to continue to understand how this protein binds to amyloid beta so we can design small molecules to do the same thing,” said Dr. Peng. By identifying midkine’s protective role, the St. Jude team has provided the scientific community with a fresh perspective and a potential new pathway for developing effective treatments to combat this devastating neurodegenerative disease.